NO164242C - Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater. - Google Patents

Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.

Info

Publication number
NO164242C
NO164242C NO851921A NO851921A NO164242C NO 164242 C NO164242 C NO 164242C NO 851921 A NO851921 A NO 851921A NO 851921 A NO851921 A NO 851921A NO 164242 C NO164242 C NO 164242C
Authority
NO
Norway
Prior art keywords
imidazo
procedure
rifamycin derivatives
preparing pyrido
pyrido
Prior art date
Application number
NO851921A
Other languages
English (en)
Other versions
NO851921L (no
NO164242B (no
Inventor
Vincenzo Cannata
Egidio Marchi
Gian Franco Tamagnone
Silvano Piani
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of NO851921L publication Critical patent/NO851921L/no
Publication of NO164242B publication Critical patent/NO164242B/no
Publication of NO164242C publication Critical patent/NO164242C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
NO851921A 1984-05-15 1985-05-14 Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater. NO164242C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03463/84A IT1199374B (it) 1984-05-15 1984-05-15 Processo per la preparazione di pirido-imidazo-rifamicine

Publications (3)

Publication Number Publication Date
NO851921L NO851921L (no) 1985-11-18
NO164242B NO164242B (no) 1990-06-05
NO164242C true NO164242C (no) 1990-09-12

Family

ID=11107845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851921A NO164242C (no) 1984-05-15 1985-05-14 Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.

Country Status (18)

Country Link
US (1) US4557866A (no)
EP (1) EP0161534B1 (no)
JP (1) JPS60252483A (no)
AR (1) AR241913A1 (no)
AT (1) ATE46512T1 (no)
AU (1) AU568934B2 (no)
CA (1) CA1215708A (no)
DE (1) DE3573120D1 (no)
DK (1) DK162647C (no)
ES (1) ES8603489A1 (no)
FI (1) FI81101C (no)
GR (1) GR851144B (no)
IE (1) IE58392B1 (no)
IT (1) IT1199374B (no)
NO (1) NO164242C (no)
PH (1) PH22007A (no)
PT (1) PT80446B (no)
ZA (1) ZA852971B (no)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
AU2002364162A1 (en) * 2001-12-13 2003-06-30 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7923553B2 (en) 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
EP1698630B1 (en) * 2005-03-03 2014-09-03 ALFA WASSERMANN S.p.A. New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
CN101594885B (zh) 2006-03-09 2017-07-18 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
JP5844961B2 (ja) 2006-08-02 2016-01-20 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線直腸ｓ状結腸炎を処置するための組成物および方法
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
KR101667534B1 (ko) * 2006-09-22 2016-10-19 씨아이피엘에이 엘티디. 리팍시민
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
SG188931A1 (en) 2008-02-25 2013-04-30 Salix Pharmaceuticals Ltd Forms of rifaximin and uses thereof
US8486956B2 (en) * 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
KR20100122937A (ko) 2008-02-26 2010-11-23 샐릭스 파마슈티컬스 리미티드 장 질환의 치료 방법
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
AU2009244190B2 (en) 2008-05-07 2016-02-25 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
CN101585843B (zh) * 2008-05-21 2011-07-06 重庆赛诺生物药业股份有限公司 一种利福昔明的制备工艺
US20110035232A1 (en) * 2008-10-02 2011-02-10 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
US7928115B2 (en) * 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
DK2350096T3 (da) * 2008-10-02 2020-03-02 Salix Pharmaceuticals Ltd Fremgangsmåder til behandling af hepatisk encephalopati
KR20110107806A (ko) 2008-12-10 2011-10-04 시플라 리미티드 리팍시민 복합체
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
KR20120025578A (ko) 2009-06-02 2012-03-15 샐릭스 파마슈티컬스 리미티드 간성 뇌병증의 치료방법
EP2475392A4 (en) 2009-09-13 2013-01-09 Salix Pharmaceuticals Ltd METHOD FOR TREATING IRRITATION SYNDROME
WO2011061519A2 (en) 2009-11-23 2011-05-26 Cipla Limited Topical foam composition
US8952159B2 (en) 2009-12-28 2015-02-10 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
AU2011218129A1 (en) 2010-02-18 2012-08-23 Board Of Regents Of The University Of Texas System Methods for treating infection
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
WO2011156897A2 (en) * 2010-06-16 2011-12-22 Apotex Pharmachem Inc. Polymorphic forms of rifaximin
MY165086A (en) 2010-07-12 2018-02-28 Salix Pharmaceuticals Ltd Formulations of rifaximin and uses thereof
US8759513B2 (en) 2010-09-13 2014-06-24 Sequent Scientific Limited Polymorphic form of rifaximin and process for its preparation
JP6076267B2 (ja) 2011-02-11 2017-02-08 サリックス ファーマスーティカルズ，リミテッド リファキシミンの形態およびその使用
CA2834829A1 (en) 2011-05-02 2012-11-08 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
WO2012155981A1 (en) 2011-05-19 2012-11-22 Friulchem Spa New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
EP2773205A4 (en) 2011-11-02 2015-03-25 Salix Pharmaceuticals Ltd METHOD FOR TREATING IRRITATION SYNDROME AND INFECTIONS
US9359374B2 (en) 2012-06-13 2016-06-07 Apotex Pharmachem Inc. Polymorphic forms of rifaximin
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
MX2015011802A (es) 2013-03-15 2016-01-08 Alfa Wassermann Spa Rifaximina para usarse en el tratamiento de infecciones vaginales.
EP2971062A2 (en) 2013-03-15 2016-01-20 ALFA WASSERMANN S.p.A. Method for diagnosing vaginal infections
US20140308350A1 (en) 2013-04-12 2014-10-16 Alfa Wassermann S.P.A. Nsaid administration and related compositions, methods and systems
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ITMI20131307A1 (it) 2013-08-02 2015-02-02 A M S A Anonima Materie Sint & Affini S P A Processo per la preparazione di refaximina k
CN103509038B (zh) * 2013-09-30 2016-01-20 浙江思贤制药有限公司 一种新晶型利福昔明ζ及其制备方法
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
WO2015171493A1 (en) 2014-05-04 2015-11-12 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
PL3546464T3 (pl) 2014-05-12 2020-11-02 Alfasigma S.P.A. Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
ES2929768T3 (es) 2016-09-30 2022-12-01 Salix Pharmaceuticals Inc Formas sólidas de dispersión de rifaximina
RU2020102511A (ru) * 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) * 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Also Published As

Publication number Publication date
FI81101B (fi) 1990-05-31
DE3573120D1 (en) 1989-10-26
GR851144B (no) 1985-11-25
EP0161534B1 (en) 1989-09-20
IE58392B1 (en) 1993-09-08
PT80446B (pt) 1987-11-11
IT8403463A0 (it) 1984-05-15
NO851921L (no) 1985-11-18
US4557866A (en) 1985-12-10
CA1215708A (en) 1986-12-23
AU568934B2 (en) 1988-01-14
PT80446A (en) 1985-06-01
EP0161534A3 (en) 1987-03-04
ZA852971B (en) 1985-12-24
FI81101C (fi) 1990-09-10
AU4251585A (en) 1985-11-21
ES543115A0 (es) 1986-01-01
DK214685A (da) 1985-11-16
ES8603489A1 (es) 1986-01-01
AR241913A1 (es) 1993-01-29
FI851907A0 (fi) 1985-05-14
DK162647B (da) 1991-11-25
NO164242B (no) 1990-06-05
PH22007A (en) 1988-05-02
IE851191L (en) 1985-11-15
EP0161534A2 (en) 1985-11-21
JPS60252483A (ja) 1985-12-13
DK162647C (da) 1992-04-13
JPH0469634B2 (no) 1992-11-06
ATE46512T1 (de) 1989-10-15
FI851907L (fi) 1985-11-16
DK214685D0 (da) 1985-05-14
IT1199374B (it) 1988-12-30

Similar Documents

Publication Publication Date Title
NO851921L (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifanycin-derivater.
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO860226L (no) Fremgangsmaate for fremstilling av 1-substituert-aryl-1,4-dihydro-4-oksonaftyridin-derivater.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
NO863608D0 (no) Fremgangsmaate for fremstilling av benzimidazolderivater.
NO862860L (no) Fremgangsmaate for fremstilling av poly-4-aminopyrrole-2-karboksamidoderivater.
NO164078C (no) Fremgangsmaate for fremstilling av emulsjoner.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
ES551410A0 (es) Procedimiento de preparar derivados rodaninicos.
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO885435D0 (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
ES542469A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
NO870828L (no) FremgangsmŸte for fremstilling av biskarbamater.
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.
NO872690L (no) FremgangsmŸte for fremstilling av mercaptoacylprolin.
IT8505129A0 (it) Procedimento per preparare 3-esometilenecefam derivati.
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
NO874958D0 (no) Fremgangsmaate for fremstilling av 1-aryloksy-3-amino-2-propanoler.

Legal Events

Date Code Title Description
MK1K Patent expired